SEC Info - United Technologies Corp/DE - ‘305B2’ on 5/11/12

SEC Info℠

Home

Help

Please Sign In

United Technologies Corp/DE – ‘305B2’ on 5/11/12 – EX-7

On: Friday, 5/11/12, at 5:10pm ET · Effective: 5/11/12 · Accession #: 1193125-12-228697 · File #: 333-167771

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/11/12  United Technologies Corp/DE       305B2       5/11/12    2:64K                                    RR Donnelley/FA

Statement of Eligibility of a Corporation Designated to Act as Trustee — Form T-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 305B2       Form T-1                                            HTML     19K 
 2: EX-7        Consolidated Report of Condition                    HTML     34K

EX-7 — Consolidated Report of Condition

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Consolidated Report of Condition

EXHIBIT 7

Consolidated Report of Condition of

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

of 700 South Flower Street, Suite 200, Los Angeles, CA 90017

At the close of business December 31, 2011, published in accordance with Federal regulatory authority instructions.


		Dollar Amounts in Thousands
ASSETS
Cash and balances due from depository institutions:
Noninterest-bearing balances and currency and coin			648
Interest-bearing balances			396
Securities:
Held-to-maturity securities			0
Available-for-sale securities			808,707
Federal funds sold and securities purchased under agreements to resell:
Federal funds sold			95,500
Securities purchased under agreements to resell			0
Loans and lease financing receivables:
Loans and leases held for sale			0
Loans and leases, net of unearned income	0
LESS: Allowance for loan and lease losses	0
Loans and leases, net of unearned income and allowance			0
Trading assets			0
Premises and fixed assets (including capitalized leases)			7,620
Other real estate owned			0
Investments in unconsolidated subsidiaries and associated companies			1
Direct and indirect investments in real estate ventures			0
Intangible assets:
Goodwill			856,313
Other intangible assets			187,688
Other assets			175,314

Total assets		$	2,132,187

LIABILITIES


Deposits:
In domestic offices		506
Noninterest-bearing	506
Interest-bearing	0
Not applicable
Federal funds purchased and securities sold under agreements to repurchase:
Federal funds purchased		0
Securities sold under agreements to repurchase		0
Trading liabilities		0
Other borrowed money:
(includes mortgage indebtedness and obligations under capitalized leases)		268,691
Not applicable
Not applicable
Subordinated notes and debentures		0
Other liabilities		228,471
Total liabilities		497,668
Not applicable

EQUITY CAPITAL

Perpetual preferred stock and related surplus		0
Common stock		1,000
Surplus (exclude all surplus related to preferred stock)		1,121,520
Not available
Retained earnings		506,347
Accumulated other comprehensive income		5,652
Other equity capital components		0
Not available
Total bank equity capital		1,634,519
Noncontrolling (minority) interests in consolidated subsidiaries		0
Total equity capital		1,634,519

Total liabilities and equity capital		2,132,187

I, Karen Bayz, CFO and Managing Director of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.


Karen Bayz		)		CFO and Managing Director

We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.


Timothy Vara, President	)
Frank P. Sulzberger, MD	)	Directors (Trustees)
William D. Lindelof, MD	)

Dates Referenced Herein and Documents Incorporated by Reference

This ‘305B2’ Filing	Date	Other Filings

Filed on / Effective on:	5/11/12
	12/31/11	10-K, 11-K
		List all Filings

↑Top